Publication: Is routine ophthalmoscopy really necessary in candidemic patients?
Loading...
Identifiers
Date
2017-10-24
Authors
Vena, Antonio
Muñoz, Patricia
Padilla, Belen
Valerio, Maricela
Sanchez, Maria Isabel
Puig-Asensio, Mireia
Fortun, Jesus
Fernandez-Ruiz, Mario
Merino, Paloma
Losa, Juan Emilio
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The purpose of this study was to determine among patients with candidemia the real rate of ophthalmoscopy and the impact of performing ocular assessment on the outcome of the disease. We performed a post hoc analysis of a prospective, multicenter, population-based candidemia surveillance program implemented in Spain during 2010-2011 (CANDIPOP). Ophthalmoscopy was performed in only 168 of the 365 patients with candidemia (46%). Ocular lesions related to candidemia were found in only 13/168 patients (7.7%), of whom 1 reported ocular symptoms (incidence of symptomatic disease in the whole population, 0.27% [1/365]). Ophthalmological findings led to a change in antifungal therapy in only 5.9% of cases (10/168), and performance of the test was not related to a better outcome. Ocular candidiasis was not associated with a worse outcome and progressed favorably in all but 1 evaluable patient, who did not experience vision loss. The low frequency of ophthalmoscopy and ocular involvement and the asymptomatic nature of ocular candidiasis, with a favorable outcome in almost all cases, lead us to reconsider the need for systematic ophthalmoscopy in all candidemic patients.
Description
MeSH Terms
Aged
Antifungal Agents
Candidemia
Female
Humans
Male
Middle Aged
Ophthalmoscopy
Prospective Studies
Spain
Antifungal Agents
Candidemia
Female
Humans
Male
Middle Aged
Ophthalmoscopy
Prospective Studies
Spain